About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

Medical Oncology Software Market

Medical Oncology Software Market Decade Long Trends, Analysis and Forecast 2025-2033

Medical Oncology Software Market by Deployment Type (Cloud, On-premise, Hybrid), by Application (Treatment Planning, Patient Record Management, Clinical Decision Support, Others), by End-user (Hospitals & Specialty Clinics, Diagnostic Centers, Research Institutes, Others), by North America (U.S., Canada) Forecast 2026-2034

Jun 7 2025

Base Year: 2025

150 Pages

Medical Oncology Software Market Decade Long Trends, Analysis and Forecast 2025-2033

Key Insights:

The Medical Oncology Software Market size was valued at USD 2.40 USD Billion in 2023 and is projected to reach USD 4.22 USD Billion by 2032, exhibiting a CAGR of 7.5 % during the forecast period. Medical Oncology Software is a type of medical software that specifically helps oncologists in managing the medical side of their patients' care, as well as, designing treatment plans and managing the clinical data related to cancer. The computer-based software systems cover Electronic Health Records (EHRs), Clinical Decision Support Systems (CDSS) as well as Treatment Planning Systems (TPS). The characteristics comprise of treatment scheduling, prescription drug interaction checks, data analysis, and outcome review. These systems can have a wide range of use from individualized therapy plans to tracking patient progress through process monitoring and data analysis to clinical trial management. Indeed, such tools are a crucial component of the application process that increases oncology practice efficiency and yields positive outcomes with no fears of data compromise or confidentiality

Medical Oncology Software Trends:

Shift towards cloud-based solutions
Increasing adoption of precision medicine and personalized treatment plans
Growing emphasis on real-time data access and collaboration
Integration of artificial intelligence (AI) and machine learning (ML) for improved decision-making

Medical Oncology Software Market Market Size and Forecast (2024-2030) — Medical Oncology Software Market Company Market Share

Driving Forces:

Surging Cancer Prevalence and Chronic Disease Burden: The global rise in cancer incidence and prevalence, coupled with the increasing number of individuals living with chronic illnesses, necessitates sophisticated and efficient medical oncology management systems. This fuels the demand for advanced software solutions capable of handling complex patient data and treatment protocols.
Demand for Optimized Treatment Planning and Delivery: Healthcare providers are increasingly seeking software solutions that streamline and optimize the entire treatment planning process. This includes features like improved workflow management, precise radiation dose calculation, and accurate drug dosage determination, all contributing to better patient outcomes and reduced treatment-related side effects.
Government Support and Regulatory Frameworks: Government initiatives worldwide are actively promoting the adoption of digital health technologies, including medical oncology software. These initiatives often involve funding programs, regulatory approvals that facilitate software implementation, and incentives for digital transformation within healthcare systems. This governmental support significantly accelerates market growth.
Technological Advancements in Medical Imaging and Radiation Therapy: Continuous advancements in medical imaging (e.g., PET/CT, MRI) and radiation therapy techniques demand sophisticated software capable of integrating and analyzing this complex data. The ability of software to leverage these advancements for improved treatment precision and personalization is a major driving force behind market expansion.
Emphasis on Value-Based Care and Improved Patient Outcomes: The shift towards value-based care models emphasizes demonstrably improved patient outcomes and cost-effectiveness. Medical oncology software facilitates this by enabling data-driven decision-making, personalized treatment plans, and efficient resource allocation, ultimately leading to better patient care and reduced healthcare expenditures.

Challenges and Restraints:

Data security and privacy concerns
Integration challenges with existing healthcare systems
Lack of interoperability between different software platforms
High implementation and maintenance costs

Emerging Trends:

Integration of patient portals for improved patient engagement
Real-time monitoring and remote patient management
Use of predictive analytics for personalized risk assessment and treatment recommendations

Growth Catalysts:

Government funding and reimbursement policies supportive of digital health solutions
Increasing collaborations between medical institutions and technology providers
Strategic partnerships and acquisitions to expand market reach

Leading Players in the Medical Oncology Software Market:

Epic Systems Corporation (U.S.)
Altai, Inc. (U.S.)
Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.)
Cerner Corporation (Oracle) (U.S.)
American Medical Software (U.S.)
Elekta (Sweden)
EndoSoft LLC (U.S.)
RaySearch Laboratories (Sweden)
Mckesson Corporation (U.S.)
Koninklijke Philips N.V. (Netherlands)

Significant developments in the Medical Oncology Software Sector:

April 2023: Epic Systems Corporation expanded its partnership with Microsoft to integrate generative artificial intelligence (AI) technology into the electronic health record. The partnership intended to increase providers’ productivity, reduce administrative burden, and improve care by giving clinicians additional time to spend with their patients.

Comprehensive Coverage Medical Oncology Software Market Report:

Market size and forecast by region, segment, and application
Competitive landscape and market share analysis
Key market trends, drivers, and challenges
Growth opportunities and potential roadblocks
Industry developments and recent technological advancements

Regional Insight:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Medical Oncology Software Market Market Share by Region - Global Geographic Distribution — Medical Oncology Software Market Regional Market Share

Pricing Analysis:

Competitive pricing strategies
Subscription models vs. one-time purchases
Impact of software updates and upgrades

Import And Export Analysis:

Global trade dynamics
Major importing and exporting countries
Tariffs and regulations affecting the market growth

Segmentation:

By Deployment:

Cloud
On-premise
Hybrid

By Application:

Treatment Planning
Patient Record Management
Clinical Decision Support
Others

By End-user:

Hospitals & Specialty Clinics
Diagnostic Centers
Research Institutes

Patent/Trademark Analysis:

Patent filing trends in medical oncology software
Key patent holders and their strategic importance
Trademark analysis for brand protection

Geographic Coverage of Medical Oncology Software Market

Higher Coverage

Lower Coverage

No Coverage

Medical Oncology Software Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 7.5 % from 2020-2034
Segmentation	By Deployment Type Cloud On-premise Hybrid By Application Treatment Planning Patient Record Management Clinical Decision Support Others By End-user Hospitals & Specialty Clinics Diagnostic Centers Research Institutes Others By Geography North America U.S. Canada

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Increasing Incidence of Cancer to Boost the Demand for Medical Oncology Software
- - 3.3. Market Restrains
  - - 3.3.1. High Risk of Cyber Attack and Data Breaching Activities Limit Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Development of Personalized Treatment Plans using Genomic Data
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Global Medical Oncology Software Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Deployment Type
  - 5.1.1. Cloud
  - 5.1.2. On-premise
  - 5.1.3. Hybrid
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Treatment Planning
  - 5.2.2. Patient Record Management
  - 5.2.3. Clinical Decision Support
  - 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - by End-user
  - 5.3.1. Hospitals & Specialty Clinics
  - 5.3.2. Diagnostic Centers
  - 5.3.3. Research Institutes
  - 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
  - 5.4.1. North America
6. Competitive Analysis
- 6.1. Global Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Epic Systems Corporation (U.S.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Altai Inc. (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Varian Medical Systems Inc. (Siemens Healthineers AG) (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Cerner Corporation (Oracle) (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 American Medical Software (U.S.)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Elekta (Sweden)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 EndoSoft LLC (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 RaySearch Laboratories (Sweden)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 MCKESSON CORPORATION (U.S.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Koninklijke Philips N.V. (Netherlands)
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)

List of Figures

Figure 1: Global Medical Oncology Software Market Revenue Breakdown (USD Billion, %) by Region 2025 & 2033
Figure 2: North America Medical Oncology Software Market Revenue (USD Billion), by Deployment Type 2025 & 2033
Figure 3: North America Medical Oncology Software Market Revenue Share (%), by Deployment Type 2025 & 2033
Figure 4: North America Medical Oncology Software Market Revenue (USD Billion), by Application 2025 & 2033
Figure 5: North America Medical Oncology Software Market Revenue Share (%), by Application 2025 & 2033
Figure 6: North America Medical Oncology Software Market Revenue (USD Billion), by End-user 2025 & 2033
Figure 7: North America Medical Oncology Software Market Revenue Share (%), by End-user 2025 & 2033
Figure 8: North America Medical Oncology Software Market Revenue (USD Billion), by Country 2025 & 2033
Figure 9: North America Medical Oncology Software Market Revenue Share (%), by Country 2025 & 2033

List of Tables

Table 1: Global Medical Oncology Software Market Revenue USD Billion Forecast, by Deployment Type 2020 & 2033
Table 2: Global Medical Oncology Software Market Revenue USD Billion Forecast, by Application 2020 & 2033
Table 3: Global Medical Oncology Software Market Revenue USD Billion Forecast, by End-user 2020 & 2033
Table 4: Global Medical Oncology Software Market Revenue USD Billion Forecast, by Region 2020 & 2033
Table 5: Global Medical Oncology Software Market Revenue USD Billion Forecast, by Deployment Type 2020 & 2033
Table 6: Global Medical Oncology Software Market Revenue USD Billion Forecast, by Application 2020 & 2033
Table 7: Global Medical Oncology Software Market Revenue USD Billion Forecast, by End-user 2020 & 2033
Table 8: Global Medical Oncology Software Market Revenue USD Billion Forecast, by Country 2020 & 2033
Table 9: U.S. Medical Oncology Software Market Revenue (USD Billion) Forecast, by Application 2020 & 2033
Table 10: Canada Medical Oncology Software Market Revenue (USD Billion) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Medical Oncology Software Market?

The projected CAGR is approximately 7.5 %.

2. Which companies are prominent players in the Medical Oncology Software Market?

Key companies in the market include Epic Systems Corporation (U.S.), Altai, Inc. (U.S.), Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.), Cerner Corporation (Oracle) (U.S.), American Medical Software (U.S.), Elekta (Sweden), EndoSoft LLC (U.S.), RaySearch Laboratories (Sweden), MCKESSON CORPORATION (U.S.), Koninklijke Philips N.V. (Netherlands).

3. What are the main segments of the Medical Oncology Software Market?

The market segments include Deployment Type, Application, End-user.

4. Can you provide details about the market size?

The market size is estimated to be USD 3.98 USD Billion as of 2022.

5. What are some drivers contributing to market growth?

Increasing Incidence of Cancer to Boost the Demand for Medical Oncology Software.

6. What are the notable trends driving market growth?

Development of Personalized Treatment Plans using Genomic Data.

7. Are there any restraints impacting market growth?

High Risk of Cyber Attack and Data Breaching Activities Limit Market Growth.

8. Can you provide examples of recent developments in the market?

April 2023: Epic Systems Corporation expanded its partnership with Microsoft to integrate generative artificial intelligence (AI) technology into the electronic health record. The partnership intended to increase providers’ productivity, reduce administrative burden, and improve care by giving clinicians additional time to spend with their patients.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4850, USD 5850, and USD 6850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD Billion.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Medical Oncology Software Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Medical Oncology Software Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Medical Oncology Software Market?

To stay informed about further developments, trends, and reports in the Medical Oncology Software Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

U.S. Oncology Drugs Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

Oncology Drugs Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Cancer Registry Software Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Oncology Information Systems Market Is Set To Reach XX USD Million By 2033, Growing At A CAGR Of 21.2

Medical Practice Management Software Market Strategic Roadmap: Analysis and Forecasts 2025-2033

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report